Evraz Plc:企業のM&A・事業提携・投資動向

◆英語タイトル:Evraz Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1824
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:113
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Evraz Plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Evraz Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Evraz Plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Evraz Plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Evraz Plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Evraz Plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Evraz Plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Evraz Plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Evraz Plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
MERGERS & ACQUISITIONS 6
Mergers and Acquisitions – Deal reports 6
PARTNERSHIP 68
Partnership – Deal reports 68
DIVESTMENTS 73
Divestments – Overview 73
Divestments – Deal reports 74
PRIVATE EQUITY & OWNERSHIP 100
Private Equity and Ownership – Deal reports 100
APPENDIX 103
Contact Us 103
About MarketLine Financial Deals Database 103
Deal Definition and Methodology 105
About MarketLine 112

List of Tables
Table 1: Evraz plc divestments volume and value trend (2014-YTD2018)
Table 2: Evraz plc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Evraz plc divestments volume and value trend (2014-YTD2018)
Figure 2: Evraz plc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Evraz Plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avaya Inc:企業の戦略的SWOT分析
    Avaya Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • eNeura Inc:医療機器:M&Aディール及び事業提携情報
    Summary eNeura Inc (eNeura) formerly eNeura Therapeutics LLC is a medical device manufacturing company that offers portable, non-invasive transcranial magnetic stimulation devices for treating migraine. The company offers products such as flagship product and eNeura Spring TMS device, among others. …
  • BioFactura Inc-製薬・医療分野:企業M&A・提携分析
    Summary BioFactura Inc (Biofactura) is a biosimilars manufacturer that discovers, develops and markets biodefense drugs and client selected novel drugs. The company offers contract services such as process development, stable cell lines, and manufacturing. Its stable cell lines offers stable mammali …
  • Fresenius Kidney Care-製薬・医療分野:企業M&A・提携分析
    Summary Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • Unilife Corporation (UNIS)-医療機器分野:企業M&A・提携分析
    Summary Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems with focus on wearable injector products. It develops, manufactures and distributes safety engineered syringes for medical device and pharmaceutical industries. The company's product port …
  • Midatech Pharma US Inc:企業の戦略的SWOT分析
    Midatech Pharma US Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Dowa Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務情報
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ethypharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ethypharm SA (Ethypharm), a subsidiary of Astorg Partners is a pharmaceutical company that develops and manufactures drugs for the treatment of pain, gastrointestinal, cancer, cardiovascular and central nervous system diseases. The company provides products such as ibuprofen, paracetamol, pr …
  • Shiseido Company, Limited:企業の戦略・SWOT・財務分析
    Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Shiseido Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DiaSorin SpA (DIA):医療機器:M&Aディール及び事業提携情報
    Summary DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techni …
  • University of Texas MD Anderson Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Heat Biologics Inc (HTBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Heat Biologics Inc (Heat Biologics) is a biopharmaceutical company which develops novel immuno therapeutics for the treatment of cancer. Its pipeline encompasses viagenpumatucel-L based investigational candidate targeted at the treatment of non-small cell lung cancer, and co-stimulatory anti …
  • ConMed Corporation (CNMD):医療機器:M&Aディール及び事業提携情報
    Summary ConMed Corporation (ConMed) is a medical technology company which manufactures and sells surgical devices and instruments for minimally invasive procedures and monitoring. The company’s major products include arthroscopes, reconstructive systems, bronchoscopy devices endoscopic ligator kit, …
  • Allegheny Technologies Incorporated:企業の戦略・SWOT・財務情報
    Allegheny Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Allegheny Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • China Pharma Holdings Inc (CPHI):企業の財務・戦略的SWOT分析
    China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Aurobindo Pharma Ltd (AUROPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceutical company which develops, manufactures and exports formulations and active pharmaceutical ingredients (API's). Its products portfolio includes active pharma ingredients, formulations, antibiotics, anti-retrovirals, anti- allergics, ga …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務分析
    Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Nestle SA:企業の戦略・SWOT・財務情報
    Nestle SA - Strategy, SWOT and Corporate Finance Report Summary Nestle SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆